Enhabit and Encompass Health Reach Settlement of $43.1 Million
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 12 2026
0mins
Should l Buy EHAB?
Source: Newsfilter
- Settlement Amount: Enhabit and Encompass Health have reached a settlement of $43.1 million in the Delaware Court of Chancery, which not only resolves their claims for attorneys' fees and mitigation damages but also reinforces investor confidence in the companies' legal standing.
- Liability Judgment: The court found that former executives committed
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EHAB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EHAB
Wall Street analysts forecast EHAB stock price to fall
5 Analyst Rating
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 13.660
Low
10.50
Averages
12.20
High
14.00
Current: 13.660
Low
10.50
Averages
12.20
High
14.00
About EHAB
Enhabit, Inc. is a provider of home health and hospice services in the United States. Its segments include Home Health and Hospice. The Home Health segment provides a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational and speech therapy, medical social work, and home health aide services. It works closely with patients, families, caregivers, and physicians to deliver data-driven, evidence-based care plans focused on patient needs and goals. Its home health services are provided by nurses, physical, occupational and speech therapists, medical social workers, and home health aides. The Hospice segment provides hospice services to terminally ill patients and their families. Hospice care focuses on the quality of life for patients experiencing an advanced, life- limiting illness by treating the symptoms of the disease, rather than the disease itself. It operates about 115 hospice agencies and 255 home health agencies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Monteverde Law Firm Investigates Multiple Biopharmaceutical Companies
- Shareholder Compensation Investigation: Monteverde Law Firm is investigating the sale of Day One Biopharmaceuticals, Inc., where shareholders are expected to receive $21.50 per share in cash, providing substantial returns and enhancing market confidence in the biopharmaceutical sector.
- Merger Transaction Analysis: The merger between CECO Environmental Corp. and Thermon Group Holdings, Inc. is expected to grant CECO shareholders approximately 62.5% ownership in the combined company, significantly boosting CECO's market position in the environmental sector.
- Cash Acquisition Opportunity: Enhabit Inc.'s sale to Kinderhook Industries, LLC is projected to yield $13.80 per share for shareholders, reflecting a direct cash return that indicates market confidence in Enhabit's future growth prospects.
- Capital Investment Outlook: The transaction involving KORE Group Holdings, Inc. with Searchlight Capital Partners, L.P. and Abry Partners is expected to provide shareholders with $9.25 per share, offering stable cash flow and enhancing KORE's attractiveness in the capital markets.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating Veris Residential, Inc. (NYSE: VRE) regarding its sale to an investor consortium led by Affinius Capital at $19.00 per share, potentially infringing on shareholder rights, encouraging shareholders to contact the firm for their rights and options.
- Cash Acquisition Scrutiny: Enhabit, Inc. (NYSE: EHAB) is being sold to Kinderhook Industries, LLC for $13.80 per share in cash, with Halper Sadeh LLC potentially seeking increased consideration or other remedies to ensure fair treatment for shareholders.
- Merger Transaction Review: CECO Environmental Corp. (NASDAQ: CECO) is merging with Thermon Group Holdings, Inc., and CECO shareholders are expected to own approximately 62.5% of the combined entity post-transaction, with Halper Sadeh LLC assessing whether this deal serves the best interests of shareholders.
- Legal Fee Arrangement: Halper Sadeh LLC offers legal services on a contingency fee basis, meaning shareholders do not incur out-of-pocket legal fees when addressing these matters, aiming to protect investor rights and pursue higher transaction compensation.
See More
Monteverde Law Firm Investigates Multiple Company Transactions
- Shareholder Compensation Investigation: Monteverde Law Firm is investigating the transaction between Arcellx, Inc. and Gilead Sciences, Inc., where Arcellx shareholders are expected to receive $115 per share in cash plus a contingent value right of $5 per share, aimed at protecting shareholder interests and ensuring transaction fairness.
- Veris Residential Transaction: Shareholders of Veris Residential, Inc. are expected to receive $19 per share in cash, with the deal led by Affinius Capital and Vista Hill Partners, reflecting investor confidence in the real estate market and its potential returns.
- Enhabit Acquisition: The transaction between Enhabit Inc. and Kinderhook Industries, LLC is expected to provide shareholders with $13.80 per share in cash, highlighting ongoing market interest and investment enthusiasm in the healthcare services sector.
- CECO Merger: The merger of CECO Environmental Corp. with Thermon Group Holdings, Inc. is projected to result in CECO shareholders owning approximately 62.5% of the combined company, indicating a strategic consolidation in the environmental services sector and future growth potential.
See More
Kaskela Law Launches Investigation into Enhabit Buyout
- Buyout Price Investigation: Kaskela Law LLC has initiated an investigation into the proposed buyout price of $13.80 per share for Enhabit, Inc., aiming to determine if this price undervalues the company and adversely affects shareholder interests.
- Acquisition Context: On February 23, 2026, Enhabit announced its agreement to be acquired by private equity firm Kinderhook Industries, after which the company's shares will cease to be publicly traded, potentially depriving investors of future appreciation opportunities.
- Shareholder Rights Protection: The investigation will assess whether Enhabit’s management breached fiduciary duties or violated securities laws, ensuring that shareholders receive adequate financial compensation in this transaction to protect their legal rights.
- Legal Consultation Channels: Kaskela Law encourages Enhabit shareholders who believe the buyout price is too low to reach out for legal advice and support, ensuring they are informed about their rights and options.
See More
Enhabit Reports Q4 Results in Line with Expectations
- Earnings Performance: Enhabit reported a Q4 non-GAAP EPS of $0.14, aligning with market expectations, indicating the company's stability in profitability.
- Revenue Growth: The company achieved Q4 revenue of $270.4 million, reflecting a 4.7% year-over-year increase, which underscores its ongoing demand and adaptability in the healthcare sector.
- Market Reaction Analysis: Despite the earnings report meeting expectations, the market's muted response suggests ongoing investor concerns regarding future growth prospects.
- Industry Context: In a backdrop of frequent M&A activity within the healthcare sector, Enhabit's performance may influence its competitive position, particularly in light of regulatory scrutiny.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating companies such as Arcellx, Inc., Veris Residential, Inc., and Enhabit, Inc. for potential violations of federal securities laws and breaches of fiduciary duties, which may impact shareholder rights.
- Arcellx Transaction: Arcellx, Inc. is being sold to Gilead Sciences, Inc. for $115.00 per share in cash plus a contingent value right of $5.00 per share, which may limit superior competing offers and affect potential shareholder returns.
- Veris Transaction: Veris Residential, Inc. is being sold for $19.00 per share to an investor consortium led by Affinius Capital and Vista Hill Partners, and Halper Sadeh LLC may seek to increase the consideration to protect shareholder interests.
- Enhabit Transaction: Enhabit, Inc. is being sold to Kinderhook Industries, LLC for $13.80 per share in cash, and Halper Sadeh LLC encourages shareholders to reach out to understand their rights and options to ensure their legal interests are protected.
See More
Monteverde Law Firm Investigates Multiple Biopharmaceutical Companies
- Shareholder Compensation Investigation: Monteverde Law Firm is investigating the sale of Day One Biopharmaceuticals, Inc., where shareholders are expected to receive $21.50 per share in cash, providing substantial returns and enhancing market confidence in the biopharmaceutical sector.
- Merger Transaction Analysis: The merger between CECO Environmental Corp. and Thermon Group Holdings, Inc. is expected to grant CECO shareholders approximately 62.5% ownership in the combined company, significantly boosting CECO's market position in the environmental sector.
- Cash Acquisition Opportunity: Enhabit Inc.'s sale to Kinderhook Industries, LLC is projected to yield $13.80 per share for shareholders, reflecting a direct cash return that indicates market confidence in Enhabit's future growth prospects.
- Capital Investment Outlook: The transaction involving KORE Group Holdings, Inc. with Searchlight Capital Partners, L.P. and Abry Partners is expected to provide shareholders with $9.25 per share, offering stable cash flow and enhancing KORE's attractiveness in the capital markets.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating Veris Residential, Inc. (NYSE: VRE) regarding its sale to an investor consortium led by Affinius Capital at $19.00 per share, potentially infringing on shareholder rights, encouraging shareholders to contact the firm for their rights and options.
- Cash Acquisition Scrutiny: Enhabit, Inc. (NYSE: EHAB) is being sold to Kinderhook Industries, LLC for $13.80 per share in cash, with Halper Sadeh LLC potentially seeking increased consideration or other remedies to ensure fair treatment for shareholders.
- Merger Transaction Review: CECO Environmental Corp. (NASDAQ: CECO) is merging with Thermon Group Holdings, Inc., and CECO shareholders are expected to own approximately 62.5% of the combined entity post-transaction, with Halper Sadeh LLC assessing whether this deal serves the best interests of shareholders.
- Legal Fee Arrangement: Halper Sadeh LLC offers legal services on a contingency fee basis, meaning shareholders do not incur out-of-pocket legal fees when addressing these matters, aiming to protect investor rights and pursue higher transaction compensation.
See More
Monteverde Law Firm Investigates Multiple Company Transactions
- Shareholder Compensation Investigation: Monteverde Law Firm is investigating the transaction between Arcellx, Inc. and Gilead Sciences, Inc., where Arcellx shareholders are expected to receive $115 per share in cash plus a contingent value right of $5 per share, aimed at protecting shareholder interests and ensuring transaction fairness.
- Veris Residential Transaction: Shareholders of Veris Residential, Inc. are expected to receive $19 per share in cash, with the deal led by Affinius Capital and Vista Hill Partners, reflecting investor confidence in the real estate market and its potential returns.
- Enhabit Acquisition: The transaction between Enhabit Inc. and Kinderhook Industries, LLC is expected to provide shareholders with $13.80 per share in cash, highlighting ongoing market interest and investment enthusiasm in the healthcare services sector.
- CECO Merger: The merger of CECO Environmental Corp. with Thermon Group Holdings, Inc. is projected to result in CECO shareholders owning approximately 62.5% of the combined company, indicating a strategic consolidation in the environmental services sector and future growth potential.
See More
Kaskela Law Launches Investigation into Enhabit Buyout
- Buyout Price Investigation: Kaskela Law LLC has initiated an investigation into the proposed buyout price of $13.80 per share for Enhabit, Inc., aiming to determine if this price undervalues the company and adversely affects shareholder interests.
- Acquisition Context: On February 23, 2026, Enhabit announced its agreement to be acquired by private equity firm Kinderhook Industries, after which the company's shares will cease to be publicly traded, potentially depriving investors of future appreciation opportunities.
- Shareholder Rights Protection: The investigation will assess whether Enhabit’s management breached fiduciary duties or violated securities laws, ensuring that shareholders receive adequate financial compensation in this transaction to protect their legal rights.
- Legal Consultation Channels: Kaskela Law encourages Enhabit shareholders who believe the buyout price is too low to reach out for legal advice and support, ensuring they are informed about their rights and options.
See More
Enhabit Reports Q4 Results in Line with Expectations
- Earnings Performance: Enhabit reported a Q4 non-GAAP EPS of $0.14, aligning with market expectations, indicating the company's stability in profitability.
- Revenue Growth: The company achieved Q4 revenue of $270.4 million, reflecting a 4.7% year-over-year increase, which underscores its ongoing demand and adaptability in the healthcare sector.
- Market Reaction Analysis: Despite the earnings report meeting expectations, the market's muted response suggests ongoing investor concerns regarding future growth prospects.
- Industry Context: In a backdrop of frequent M&A activity within the healthcare sector, Enhabit's performance may influence its competitive position, particularly in light of regulatory scrutiny.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating companies such as Arcellx, Inc., Veris Residential, Inc., and Enhabit, Inc. for potential violations of federal securities laws and breaches of fiduciary duties, which may impact shareholder rights.
- Arcellx Transaction: Arcellx, Inc. is being sold to Gilead Sciences, Inc. for $115.00 per share in cash plus a contingent value right of $5.00 per share, which may limit superior competing offers and affect potential shareholder returns.
- Veris Transaction: Veris Residential, Inc. is being sold for $19.00 per share to an investor consortium led by Affinius Capital and Vista Hill Partners, and Halper Sadeh LLC may seek to increase the consideration to protect shareholder interests.
- Enhabit Transaction: Enhabit, Inc. is being sold to Kinderhook Industries, LLC for $13.80 per share in cash, and Halper Sadeh LLC encourages shareholders to reach out to understand their rights and options to ensure their legal interests are protected.
See More
